WST vs ALC
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
WST · West Pharmaceutical Services$399.81 ▲ 1.87%
ALC · Alcon$74.94 ▼ 2.10%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- WST +45.6%
- ALC +1.9%
Head to head
| Metric | WST | ALC |
|---|---|---|
| Price | $399.81 | $74.94 |
| Change today | ▲ 1.87% | ▼ 2.10% |
| Market cap | $27.85B | $36.23B |
| Return, 3 months | +13.5% | +1.8% |
| Return, year to date | +45.7% | -3.8% |
| Return, 1 year | +48.0% | +2.5% |
| P/E (TTM) | 44.9 | 57.2 |
| P/B | 9.4 | 1.7 |
| P/E percentile vs own 5y | 60th | 54th |
| Dividend yield | 0.22% | 0.47% |
| Revenue growth (YoY, latest qtr) | +13.8% | +8.7% |
| Net profit growth (YoY) | +16.8% | -100.0% |
| Gross margin | 36.8% | 56.8% |
| Operating margin | 21.7% | 8.7% |
| Net margin | 17.0% | 5.9% |
| Return on equity | 19.1% | 2.9% |
| Analyst target vs. price | +19.6% | +11.6% |
| Analyst buy share | 100% | 62% |
| RSI (14) | 58 | 66 |
| 30-day volatility | 24.0% | 32.6% |
| Max drawdown, 1 year | -19.5% | -28.0% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ALC is the largest of the group by market value.
- WST has returned the most over the past year.
- WST carries the lowest trailing P/E.
- ALC pays the highest dividend yield.
- WST is growing revenue fastest.
- WST keeps the most profit per dollar of sales.
- WST has been the calmest stock over the last 30 days.